TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,203,203 | +54.1% | 1,468,802 | +2.6% | 0.00% | – |
| Q4 2022 | $1,429,628 | -44.6% | 1,431,346 | -0.1% | 0.00% | – |
| Q3 2022 | $2,581,000 | -33.3% | 1,433,425 | +7.4% | 0.00% | – |
| Q2 2022 | $3,869,000 | +36.0% | 1,334,359 | +29.4% | 0.00% | – |
| Q1 2022 | $2,845,000 | -54.8% | 1,030,897 | -23.7% | 0.00% | – |
| Q4 2021 | $6,295,000 | -49.1% | 1,350,777 | -7.1% | 0.00% | – |
| Q3 2021 | $12,373,000 | -45.7% | 1,454,072 | +4.7% | 0.00% | -100.0% |
| Q2 2021 | $22,800,000 | -24.7% | 1,389,360 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $30,282,000 | -13.8% | 1,371,503 | +20.7% | 0.00% | 0.0% |
| Q4 2020 | $35,146,000 | +58.8% | 1,136,322 | +4.3% | 0.00% | 0.0% |
| Q3 2020 | $22,131,000 | +181.1% | 1,089,091 | +112.5% | 0.00% | – |
| Q2 2020 | $7,872,000 | +108.8% | 512,470 | +5.2% | 0.00% | – |
| Q1 2020 | $3,770,000 | -44.8% | 487,003 | +1.8% | 0.00% | – |
| Q4 2019 | $6,830,000 | -2.3% | 478,255 | +2.8% | 0.00% | – |
| Q3 2019 | $6,994,000 | +553.6% | 465,369 | +522.3% | 0.00% | – |
| Q2 2019 | $1,070,000 | – | 74,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |